Paperpal Prime Logo

Hepatology : Impact Factor & More

eISSN: 1527-3350pISSN: 0270-9139

Key Metrics

CiteScore
25.8
H-Index
387
Impact Factor
10 - 15
Scite Index
0.89 5-Year SI
SJR
Q1Hepatology
SNIP
3.92
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatology

Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatology

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
  • 7 Aug 2026
  • Hepatology (Baltimore, Md.)
With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.
  • 6 Aug 2026
  • Hepatology (Baltimore, Md.)
Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).
  • 4 Aug 2026
  • Hepatology (Baltimore, Md.)
Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD.
  • 4 Aug 2026
  • Hepatology (Baltimore, Md.)
Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.
  • 3 Aug 2026
  • Hepatology (Baltimore, Md.)
Erratum: AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
  • 1 Aug 2026
  • Hepatology (Baltimore, Md.)
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
  • 7 Aug 2026
  • Hepatology (Baltimore, Md.)
With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.
  • 6 Aug 2026
  • Hepatology (Baltimore, Md.)
Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).
  • 4 Aug 2026
  • Hepatology (Baltimore, Md.)
Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD.
  • 4 Aug 2026
  • Hepatology (Baltimore, Md.)
Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.
  • 3 Aug 2026
  • Hepatology (Baltimore, Md.)
Erratum: AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
  • 1 Aug 2026
  • Hepatology (Baltimore, Md.)

FAQs on Hepatology